Multiple Sclersosis
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Groningen
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: Criteria for inclusion: confirmed diagnosis of MS (subtypes: remitting MS [RRMS], primary progressive MS [PPMS] and secondary progressive MS [SPMS]), age 18 to 70, being able to participate in a short neuropsychological assessment (NPA) as judged by the MS clinician (neurologist, rehabilitation physician) and/or investigator (neuropsychologist), with adequate control of the Dutch language. In order to be eligible to participate in this study, the group of HC*s must be matched to the patient group on age and education level. This will be done by the investigator (experienced neuropsychologist).
Exclusion criteria
Exclusion criteria: Patients as well as HC*s whose physical and/or cognitive condition is impaired in such a way that they are not able to complete the NPA cannot participate in this study. In addition, patients and HC*s cannot participate when they suffer from other self-reported neurological and/or major psychiatric conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter is CEBA profile, which is latent and thus needs to be derived from the neuropsychological tests and questionnaires regarding the CEBA domains, using latent profile analysis. See 8. METHOD of the research protocol for the neuropsychological tests and questionnaires used in each of the CEBA domains. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary parameters are demographic information (derived from medical records), level of societal participation (derived from the score on the Impact on Participation and Autonomy (IPA) questionnaire), and subjective burden (obtained by conducting a short anamnesis). | — |
Countries
Netherlands
Contacts
Public ContactA Reinhardt
Universitair Medisch Centrum Groningen
Outcome results
None listed